Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Hepatology ; 44(4): 936-44, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17006910

ABSTRACT

Hepatitis C virus (HCV) infection causes acute and chronic liver disease often leading to liver cirrhosis and hepatocellular carcinoma. Numerous studies have shown that despite induction of virus specific immunity, a curative response is often not attained; this has led to the hypothesis that HCV genes modulate immunity, thereby enabling chronic infections. This study examined the effects on immune-mediated liver injury in transgenic mice expressing core protein throughout the body and bone marrow chimeras expressing core protein in either the lymphoid compartment or liver parenchyma. Presence of core protein in the liver parenchyma but not in lymphoid cells protects from autoimmune hepatitis induced by mitogen concanavalin A (ConA). Consistent with this observation, core transgenic hepatocytes are relatively resistant to death induced by anti-Fas antibody and tumor necrosis factor alpha (TNFalpha). This protective effect is associated with preferential activation of signal transducer and activation of transcription factor 3 (STAT3) versus STAT1 in livers of ConA-injected animals. In agreement with this effect of core protein on the Janus kinase (JAK)-STAT signaling pathway, transgenic mice accelerate liver regeneration after partial hepatectomy but are not protected from hepatocyte death. In conclusion, HCV core inhibits STAT1 and stimulates STAT3 activation, which protects infected hepatocytes from attack by the cell-mediated immune system and promotes their proliferation.


Subject(s)
Apoptosis/drug effects , Hepacivirus/genetics , Hepatitis, Autoimmune/virology , Hepatocytes/metabolism , Liver Regeneration/physiology , Viral Core Proteins/genetics , Alanine Transaminase/metabolism , Animals , Antibodies, Monoclonal/pharmacology , Antibodies, Monoclonal, Murine-Derived , Caspase 3 , Caspases/metabolism , Chimera , Concanavalin A , Female , Hepacivirus/immunology , Hepatitis, Autoimmune/etiology , Hepatitis, Autoimmune/physiopathology , Hepatocytes/drug effects , Hepatocytes/virology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Phosphorylation , STAT1 Transcription Factor/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction/physiology , Tumor Necrosis Factor-alpha/pharmacology , Viral Core Proteins/metabolism
2.
J Immunol ; 176(4): 2152-60, 2006 Feb 15.
Article in English | MEDLINE | ID: mdl-16455971

ABSTRACT

Adenine nucleotides induce danger signals in T cells via purinergic receptors, raising the question whether they exert similar effects on innate immunity. Here we show that micromolar concentrations of nicotinamide adenine dinucleotide (NAD) induce a rapid increase of annexin V staining in NKT cells in vitro, a response that requires expression of P2X(7)Rs. Consistent with this result, treatment of mice with NAD causes a temporary decrease of NKT cells in the liver and protects from Con A- and alpha-galactosylceramide-induced hepatitis, both of which require functional NKT cells. Resistance to liver injury is associated with decreased cytokine production by NKT cells in NAD-treated mice. In contrast, when NAD is injected into Con A- or alpha-galactosylceramide-primed mice, liver injury is exacerbated and cytokine production by NKT cells is increased. This effect is caused by P2X(7)R-mediated stimulation of activated NKT cells. In agreement, mice lacking P2X(7)Rs on lymphocytes suffer reduced liver injury, and animals lacking ADP-ribosyltransferase, the enzyme that uses NAD to attach ADP-ribosyl groups to cell surfaces, are also resistant to Con A-induced hepatitis. These results prompt the conclusion that engagement of P2X(7)Rs on NKT cells inhibits naive, while stimulating activated cells, resulting in suppression or stimulation of autoimmune hepatitis.


Subject(s)
Hepatitis, Autoimmune/immunology , Hepatitis, Autoimmune/metabolism , Receptors, Purinergic P2/metabolism , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , Animals , Annexin A5/metabolism , Cells, Cultured , Cytokines/biosynthesis , Female , Hepatitis, Autoimmune/prevention & control , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Liver/injuries , Liver/metabolism , Liver/pathology , Lymphocyte Activation , Macrolides/metabolism , Macrolides/pharmacology , Mice , Mice, Knockout , NAD/pharmacology , Receptors, Purinergic P2/deficiency , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2X7 , T-Lymphocytes, Regulatory/drug effects
3.
Cell Immunol ; 243(1): 58-65, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17286969

ABSTRACT

Contact of T lymphocytes with nicotinamide adenine dinucleotide (NAD) or ATP causes cell death that requires expression of purinergic receptor P2X(7) (P2X(7)R). T cell subsets differ in their responses to NAD and ATP, which awaits a mechanistic explanation. Here, we show that sensitivity to ATP correlates with P2X(7)R expression levels in CD4 cells, CD8 cells and CD4(+)CD25(+) cells from both C57BL/6 and BALB/c mice. But P2X(7)R ligands do not only induce cell death but also shedding of CD62L. It is shown here that in CD62L(high) T cells, CD62L shedding correlates with low expression of P2X(7)Rs and lower cell death, whereas in CD62L(low) cells P2X(7)R expression and death are higher. The possibility is therefore investigated that P2X(7)Rs induce T cell activation. Experiments show that spontaneous T cell proliferation is somewhat higher in cells expressing P2X(7)Rs, but this effect we suggest is caused by P2X(7)R expression on accessory cells.


Subject(s)
Adenosine Triphosphate/pharmacology , Purines/chemistry , Receptors, Purinergic P2/metabolism , Signal Transduction , T-Lymphocytes/metabolism , Animals , CD4-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/drug effects , Cell Death , Cell Proliferation , Dose-Response Relationship, Drug , Female , Interleukin-2 Receptor alpha Subunit/metabolism , L-Selectin/metabolism , Ligands , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Receptors, Purinergic P2X7 , T-Lymphocytes/drug effects
4.
Crit Rev Immunol ; 26(5): 453-73, 2006.
Article in English | MEDLINE | ID: mdl-17341188

ABSTRACT

NKT cells expressing invariant T-cell receptors are an abundant cell population in the mouse liver, and much evidence has been accumulating which shows that they play an important role in immune responses in this organ. In this review, the putative function of NKT cells in autoimmune hepatitis is discussed based on results from various mouse models. Features and functions of invariant NKT cells are summarized to set the stage to explain how these cells induce liver injury following the injection of mitogen concanavalin A or NKT-cell receptor ligand alpha-GalCer. Results are discussed which show that alcohol consumption can aggravate liver injury by NKT cells, whereas expression of a hepatitis C virus protein in hepatocytes can protect against injury. Hepatocytes, therefore, can modulate sensitivity to NKT-cell-mediated attack. Moreover, experiments that elucidate how NKT cells induce liver injury and how they are regulated to perform this function are discussed. Specific attention is given to the recently discovered role of purinergic receptor P2X7 in regulating NKT cells. The conclusion is drawn that the P2X7 receptor constitutes a sensor that senses purine-based danger signals, which trigger mechanisms that cause inhibition or stimulation of NKT-cell functions.


Subject(s)
Disease Models, Animal , Hepatitis, Autoimmune/immunology , T-Lymphocytes, Regulatory/immunology , Animals , Hepatitis, Autoimmune/metabolism , Humans , Liver/immunology , Liver/injuries , Liver/metabolism , Sensitivity and Specificity , Signal Transduction , T-Lymphocytes, Regulatory/metabolism
5.
J Immunol ; 175(5): 3075-83, 2005 Sep 01.
Article in English | MEDLINE | ID: mdl-16116196

ABSTRACT

Although regulatory lymphocytes play an important role in the immune system, the regulation of their functions is poorly understood and remains to be elucidated. In this study we demonstrate that micromolar concentrations of the common cell metabolite NAD induce death in murine forkhead/winged helix transcription factor gene-expressing CD4+CD25+ regulatory T cells with high efficiency and within minutes. Similar, but less dramatic, effects are demonstrable with ATP and its nonhydrolysable derivative, benzoylbenzoyl-ATP. Other T cell subsets are more resistant, with CD8 cells being the least sensitive and CD4 cells expressing intermediate sensitivity. The higher sensitivity of CD4+CD25+ cells is demonstrable in vivo. Injection of NAD or benzoylbenzoyl-ATP causes preferential induction of a cell death signal in CD4+CD25+ cells. Transmission of the death signal requires functional P2X7 receptors, pointing to a role for these receptors in regulation and homeostasis of CD4+CD25+ regulatory T cells. Consistent with this, P2X7R gene-deleted mice possess increased levels of forkhead/winged helix transcription factor gene-expressing CD4+CD25+ cells.


Subject(s)
Adenosine Triphosphate/pharmacology , NAD/pharmacology , Receptors, Interleukin-2/analysis , Receptors, Purinergic P2/physiology , T-Lymphocytes, Regulatory/drug effects , ADP Ribose Transferases/analysis , Adenosine Triphosphate/analogs & derivatives , Animals , Apoptosis/drug effects , DNA-Binding Proteins/analysis , Female , Forkhead Transcription Factors , Mice , Mice, Inbred C57BL , Receptors, Interleukin-2/physiology , Receptors, Purinergic P2X7 , T-Lymphocytes, Regulatory/physiology
6.
Liver Int ; 25(3): 622-32, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15910500

ABSTRACT

BACKGROUND: Injection of adenoviral constructs causes liver infection prompting immunity, which suppress viral gene expression. Innate and adaptive immunity mediate these processes raising the question which pathways are the most prominent. METHODS: Adenovirus expressing the beta-galactosidase (beta-gal) gene was injected into normal and immunodeficient mice. Elimination of beta-gal-expressing hepatocytes and increases in liver enzymes were assayed. Major histocompatibility complex (MHC) class I densities, perforin channel insertion and apoptosis by Fas and tumor necrosis factor (TNF)-alpha were assayed. RESULTS: At high virus doses, suppression of viral gene expression was as efficient in immunodeficient as in normal mice, while at low doses effects of cytotoxic T lymphocytes (CTL) were demonstrable. Despite CTL priming and elimination of infected hepatocytes no liver injury is detected. Hepatocyte MHC I densities were able to trigger CTL granule exocytosis and perforin lysis in vitro but not in vivo. This is we show is because of decreased sensitivity of hepatocytes from infected mice to perforin and increased sensitivity to Fas and TNF-alpha lysis. CONCLUSION: Effector cells of the innate immune system are exceedingly effective in suppressing adenoviral gene expression. Perforin-independent pathways, those mediated by TNF-alpha and Fas are very efficient in hepatocytes from virus-infected livers.


Subject(s)
Adenoviridae/genetics , Gene Expression Regulation, Viral/immunology , Hepatitis, Viral, Human/immunology , Hepatitis, Viral, Human/virology , Animals , B-Lymphocytes/immunology , Carcinoma, Hepatocellular , Cell Line, Tumor , Female , Hepatocytes/immunology , Hepatocytes/metabolism , Hepatocytes/virology , Homeodomain Proteins/genetics , Liver/immunology , Liver/virology , Liver Neoplasms , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Perforin , Pore Forming Cytotoxic Proteins , T-Lymphocytes/immunology , Tumor Necrosis Factor-alpha/metabolism , fas Receptor/metabolism
7.
J Immunol ; 174(4): 1971-9, 2005 Feb 15.
Article in English | MEDLINE | ID: mdl-15699125

ABSTRACT

Adding NAD to murine T lymphocytes inhibits their functions and induces annexin V binding. This report shows that NAD induces cell death in a subset of T cells within seconds whereas others do not die until many hours later. Low NAD concentrations (<10 microM) suffice to trigger rapid cell death, which is associated with annexin V binding and membrane pore formation, is not blocked by the caspase inhibitor Z-VADfmk, and requires functional P2X7 receptors. The slower induction of death requires higher NAD concentrations (>100 microM), is blocked by caspase inhibitor Z-VADfmk, is associated with DNA fragmentation, and does not require P2X7 receptors. T cells degrade NAD to ADP-ribose (ADPR), and adding ADPR to T cells leads to slow but not rapid cell death. NAD but not ADPR provides the substrate for ADP-ribosyltransferase (ART-2)-mediated attachment of ADP-ribosyl groups to cell surface proteins; expression of ART-2 is required for NAD to trigger rapid but not slow cell death. These results support the hypothesis that cell surface ART-2 uses NAD but not ADPR to attach ADP-ribosyl groups to the cell surface, and that these groups act as ligands for P2X7 receptors that then induce rapid cell death. Adding either NAD or ADPR also triggers a different set of mechanisms, not requiring ART-2 or P2X7 receptors that more slowly induce cell death.


Subject(s)
Growth Inhibitors/pharmacology , NAD/analogs & derivatives , NAD/pharmacology , Receptors, Purinergic P2/physiology , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , ADP Ribose Transferases/physiology , Adenosine Diphosphate Ribose/pharmacology , Animals , Apoptosis/immunology , Cell Death/drug effects , Cell Death/immunology , Cell Proliferation/drug effects , Cells, Cultured , Female , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred NOD , Mice, Knockout , NAD/metabolism , Receptors, Purinergic P2/deficiency , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2X7 , Signal Transduction/drug effects , Signal Transduction/immunology , Substrate Specificity , T-Lymphocytes/drug effects , T-Lymphocytes/enzymology , Time Factors
8.
Gastroenterology ; 126(5): 1387-99, 2004 May.
Article in English | MEDLINE | ID: mdl-15131799

ABSTRACT

BACKGROUND & AIMS: Chronic alcohol abuse induces liver injury and increases the severity of viral hepatitis, but the precise mechanisms responsible are not well understood. In particular, little is known about the role of natural killer T cells in alcohol-induced liver injury. Natural killer T cells are mediators of important regulator and effector functions making use of Fas and tumor necrosis factor (TNF)-alpha in apoptosis induction. This report analyzes the role of natural killer T cells, Fas, and TNF-alpha in a model of chronic alcohol consumption. METHODS: Mice fed alcohol by intragastric tube were assayed for serum alanine aminotransferase values, liver histology, and liver mononuclear cells before and after activation of natural killer T cells by ligand alpha-galactosylceramide. RESULTS: In alcohol-consuming animals, liver natural killer T cells increase, and further activation by alpha-galactosylceramide causes lethal liver injury. This is explained by alcohol-induced hepatocyte sensitization to cell-mediated lysis, which develops concomitant to increased cytolytic activity of natural killer T cells. Natural killer T cell-mediated apoptosis proceeds by the Fas pathway, and Fas is essential for alcohol-associated liver injury. TNF-alpha plays an additional role as a defect in TNF receptor-1 inhibits alcohol-associated liver injury. Alcohol-fed natural killer T cell-deficient Jalpha281(-/-) mice express a delay in alcohol-induced liver injury. CONCLUSIONS: Alcohol consumption induces an increase of natural killer T cells in the liver and a high sensitivity of hepatocytes to cell-mediated lysis. Stimulation of natural killer T cells during alcohol consumption induces serious liver injury by a mechanism that involves concomitant signals by Fas and tumor necrosis factor receptor-1 on alcohol-stressed hepatocytes.


Subject(s)
Alcohol Drinking/physiopathology , Killer Cells, Natural , Tumor Necrosis Factor-alpha/metabolism , fas Receptor/metabolism , Alcohol Drinking/metabolism , Animals , Antigens, CD/metabolism , Apoptosis , Chemical and Drug Induced Liver Injury , Fas Ligand Protein , Female , Galactosylceramides/administration & dosage , Hepatocytes , Injections , Killer Cells, Natural/metabolism , Killer Cells, Natural/pathology , Liver/drug effects , Liver/pathology , Liver Diseases/mortality , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Tumor Necrosis Factor/metabolism , Receptors, Tumor Necrosis Factor, Type I , Signal Transduction
9.
Cell Immunol ; 219(1): 48-56, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12473267

ABSTRACT

Viral infection of the liver causes accumulation of T cells in the infected organ, raising the question as to the signals that mediate this response. Employing an adenovirus induced hepatitis model in mice, we show that IP-10 and Mig are essential for T cell recruitment and that induction of the two chemokines occurs concomitant to production of IFNgamma. It is shown that while IFNgamma induces IP-10 and Mig in hepatocytes, for optimal chemokine induction, a co-stimulatory signal mediated by cross-linking of Fas on hepatocytes is required. Moreover, cross-linking of Fas by injection of anti-Fas antibody into mice triggers induction of IP-10 and Mig in the liver. The cells providing the two signals are shown to express NK1.1 and AsGM1; elimination of these cells leads to inhibition of IFNgamma and chemokine transcript induction. The conclusion is drawn that both NK cells and T cells provide the two signals for induction of IP-10 and Mig in the liver.


Subject(s)
Adenoviridae Infections/immunology , Chemokines, CXC/physiology , Hepatitis, Viral, Animal/immunology , Intercellular Signaling Peptides and Proteins , Liver/immunology , T-Lymphocytes/immunology , Animals , Antibodies/pharmacology , Antigens/analysis , Antigens, Ly , Antigens, Surface/analysis , Cell Line , Chemokine CXCL10 , Chemokine CXCL9 , Chemokines, CXC/antagonists & inhibitors , Chemokines, CXC/biosynthesis , Disease Models, Animal , Female , G(M1) Ganglioside/analysis , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/biosynthesis , Interferon-gamma/pharmacology , Killer Cells, Natural/immunology , Lectins, C-Type , Lymphocyte Subsets/immunology , Mice , Mice, Inbred C57BL , Mice, SCID , NK Cell Lectin-Like Receptor Subfamily B , Proteins/analysis , Signal Transduction , Up-Regulation , fas Receptor/biosynthesis , fas Receptor/pharmacology
10.
Crit Rev Immunol ; 22(1): 1-11, 2002.
Article in English | MEDLINE | ID: mdl-12186186

ABSTRACT

Immune responses in the liver have been studied for more than three decades, raising intriguing questions but providing few definitive answers. Many observations pertaining to immunity in this organ are unexpected and some of them even contradictory: parenchymal cells in the liver are readily accessible to circulating lymphocytes and may function as antigen-presenting cells (APC), yet antigens expressed in the liver often fail to induce responses and may cause systemic tolerance. There are rare lymphocyte classes in the liver, yet reasons why these cells reside in this organ and why immune responses are often poor remain to be elucidated. Here one of the central questions in immune responses in the liver is discussed (i.e., the ability of the adaptive T-cell-mediated immune response to clear a virus infection). An attempt is made to explain the intriguing observation that non-self-antigens expressed in the liver may induce unresponsiveness. It is shown that cell-mediated immunity to a viral infection is terminated, coincident with cell death of virus-specific cytotoxic T-lymphocytes (CTL) early after infection. Death of CTL is shown to involve interaction of Fas with Fas ligand, pointing to fratricide between activated CTL. The observation that T-cell death is inhibitable by injection of interleuken-2 is interpreted to point to a mechanism involving insufficient stimulation of T cells in conjunction with a death signal by Fas. The hypothesis is put forward that antigen presentation by unconventional APC in the liver leads to T-cell activation, in turn inducing lytic activity and expression of Fas and FasL on CTL. CTL then commit fratricide, aided by insufficient cytokine production and resulting in clonal elimination of virus-specific T cells and induction of tolerance.


Subject(s)
Cytotoxicity, Immunologic , Liver/immunology , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Cytotoxic/pathology , Animals , Apoptosis , Hepatitis/immunology , Humans , T-Lymphocytes, Cytotoxic/metabolism , T-Lymphocytes, Cytotoxic/virology
11.
J Virol ; 76(3): 990-7, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11773374

ABSTRACT

The hepatitis C virus (HCV) core protein is among the most conserved proteins in HCV and is known to induce sensitization of cytotoxic T lymphocytes (CTL). Therefore, it is a prime candidate for a component of a potential HCV vaccine. The HCV core protein has, however, been reported to exert multiple effects on cell functions, raising questions as to its suitability for this purpose. This question was investigated here with mice into which replication-deficient adenoviruses expressing core protein of an HCV genotype 1b isolate were injected. We show that induction of cytokines in response to the infection, infiltration of lymphocytes into the infected liver, priming of virus-specific CTL, and liver injury are not modulated by expression of the core protein in the liver. Moreover, no changes in the sensitivity to tumor necrosis factor alpha- or Fas-mediated liver injury are demonstrable. A similar lack of demonstrable effects of the core protein on immune functions has also been obtained using transgenic mice expressing another HCV genotype 1b core protein. It is concluded that the HCV core protein of genotype 1b has no modulatory effects on induction of virus-specific immune responses and may therefore be a suitable component of an HCV vaccine.


Subject(s)
Hepacivirus/immunology , T-Lymphocytes, Cytotoxic/immunology , Viral Core Proteins/immunology , Adenoviruses, Human , Alanine Transaminase/blood , Animals , Female , Gene Expression , Genetic Vectors , Genotype , Hepacivirus/genetics , Humans , Immunity, Cellular , Interferon-gamma/biosynthesis , Interleukin-12/biosynthesis , Interleukin-18/biosynthesis , Liver/immunology , Liver/metabolism , Mice , Mice, Inbred C57BL , Recombination, Genetic , Tumor Necrosis Factor-alpha/immunology , Viral Core Proteins/biosynthesis , Viral Core Proteins/genetics , fas Receptor/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...